Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Infinity Natural valued at $1.3 billion in debut as US energy IPOs rebound
Infinity Natural Resources was valued at $1.30 billion after its shares jumped nearly 11% in their NYSE debut on Friday, underscoring a rebound in energy listings against the backdrop of a more fossil fuel-friendly Trump administration.
Opening Day: Infinity Natural Resources valued at $1.3B in market debut
Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing
Oil company Infinity Natural Resources debuts IPO amid deregulation push
Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong stock-market debut for the oil and gas producer, which operates in Ohio and Pennsylvania.
Pearl Energy-backed Infinity Natural Resources raises $265 mln in US IPO
Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial public offering in the United States.
Infinity Natural Resources launches IPO, starts trading 11% higher
Infinity Natural Resources, an independent energy company, has launched its initial public offering (IPO) today. The company priced 13,250,000 shares of its Class A common stock at $20.00 each. Trading commenced on the New York Stock Exchange (NYSE) under the ticker symbol "INR",
22h
on MSN
Unilever considering IPO of ice cream business in the US - Bloomberg
Unilever Plc (NYSE:UL) is evaluating an initial public offering of its ice cream business in the U.S. The company is also ...
4d
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
WBEZ
4h
White activists sue Bally’s over Chicago casino IPO limited to women, minorities
Bally's announced a $250 million public offering last month for shares of its massive Chicago casino project, but only to ...
2d
Northpointe Bancshares Begins $201 Million IPO Effort
Northpointe Bancshares plans $201.25M IPO for retail banking, residential lending, and digital deposit banking. Explore more ...
3d
on MSN
Smithfield Foods to keep US pork plants open, eyes tariffs amid IPO, CEO says
Smithfield Foods does not plan to close more U.S. pork processing plants, Chief Executive Shane Smith said on Tuesday, as the ...
4d
on MSN
US Pork Giant Smithfield Foods Raises $522M After Pricing IPO Below Range
Smithfield Foods and its Chinese parent raised around $522 million from the U.S. pork giant's initial public offering after ...
4d
Cement Producer Titan America Seeks up to $3.3 Billion Valuation in US IPO
(Reuters) - Titan America is seeking a valuation of up to $3.32 billion in its New York initial public offering, the ...
4d
Titan America Sets IPO Terms That Could Push Market Cap Above $3 Billion
Titan America, which makes heavy building materials and operates primarily on the U.S. Eastern Seaboard, on Tuesday said it plans to sell 9 million shares at between $15 and $18 apiece in the IPO, for ...
4d
on MSN
J&J-Backed Medtech Firm HistoSonics Considers US IPO
HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...
Upstream
2d
What Venture Global’s IPO means for its founders' net worth — and for the company
Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...
4d
Karman Holdings Aims High With $100 Million US IPO Plan
Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...
7d
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback